BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
MVB Financial
MVBF
$305M
| $8.01K | ﹤0.01% |
602
-2,353
| -80% | -$31.3K |
|
3027
FVCBankcorp
FVCB
$240M
| $7.95K | ﹤0.01% |
924
-3,777
| -80% | -$32.5K |
|
3028
Organogenesis Holdings
ORGO
$617M
| $7.95K | ﹤0.01% |
2,069
-1,397
| -40% | -$5.37K |
|
|
MGI
3029
DELISTED
MoneyGram International, Inc. New
MGI
| $7.94K | ﹤0.01% |
2,473
+2,219
| +874% | +$7.12K |
|
3030
Siebert Financial
SIEB
$108M
| $7.93K | ﹤0.01% |
1,568
-894
| -36% | -$4.52K |
|
3031
Savara
SVRA
$662M
| $7.92K | ﹤0.01% |
3,179
-9,567
| -75% | -$23.8K |
|
|
GCAP
3032
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $7.89K | ﹤0.01% |
1,311
-4,678
| -78% | -$28.2K |
|
3033
Oppenheimer Holdings
OPY
$763M
| $7.89K | ﹤0.01% |
362
-2,599
| -88% | -$56.6K |
|
3034
Verrica Pharmaceuticals
VRCA
$47.7M
| $7.88K | ﹤0.01% |
72
-330
| -82% | -$36.1K |
|
|
BOCH
3035
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $7.87K | ﹤0.01% |
1,038
-4,394
| -81% | -$33.3K |
|
3036
Red River Bancshares
RRBI
$431M
| $7.86K | ﹤0.01% |
179
-1,337
| -88% | -$58.7K |
|
|
SCPL
3037
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $7.83K | ﹤0.01% |
528
| – | – |
|
|
EVLO
3038
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $7.83K | ﹤0.01% |
80
-131
| -62% | -$12.8K |
|
|
TACO
3039
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $7.83K | ﹤0.01% |
1,320
-7,581
| -85% | -$45K |
|
3040
United Security Bancshares
UBFO
$166M
| $7.77K | ﹤0.01% |
1,161
-3,083
| -73% | -$20.6K |
|
3041
Wave Life Sciences
WVE
$1.18B
| $7.77K | ﹤0.01% |
746
-6,243
| -89% | -$65K |
|
3042
Guaranty Bancshares
GNTY
$552M
| $7.76K | ﹤0.01% |
330
-2,442
| -88% | -$57.4K |
|
3043
ProShares Ultra Utilities
UPW
$13.4M
| $7.74K | ﹤0.01% |
+168
| New | +$7.74K |
|
|
SMMF
3044
DELISTED
Summit Financial Group, Inc.
SMMF
| $7.73K | ﹤0.01% |
469
-2,925
| -86% | -$48.2K |
|
3045
Xeris Biopharma Holdings
XERS
$1.26B
| $7.73K | ﹤0.01% |
2,904
-6,330
| -69% | -$16.8K |
|
3046
Cyclerion Therapeutics
CYCN
$7.57M
| $7.72K | ﹤0.01% |
65
-307
| -83% | -$36.5K |
|
3047
Global Indemnity Group
GBLI
$419M
| $7.71K | ﹤0.01% |
322
-2,268
| -88% | -$54.3K |
|
|
MCF
3048
DELISTED
Contango Oil & Gas Co.
MCF
| $7.69K | ﹤0.01% |
3,360
+3,359
| +335,900% | +$7.69K |
|
3049
Eletrobras Common Shares
EBR
$19.1B
| $7.67K | ﹤0.01% |
1,352
+1,119
| +480% | +$6.35K |
|
3050
XBiotech
XBIT
$85.4M
| $7.66K | ﹤0.01% |
559
-5,866
| -91% | -$80.4K |
|